Today during an emergency meeting, the independent group of vaccine experts, ACIP (the Advisory Committee on Immunization Practices), called for the Johnson & Johnson (J&J) COVID-19 vaccine to stay "on pause" as the group gathers more data on the potential link between the one-dose vaccine and life-threatening blood clots.Members said they needed to reconvene as quickly as possible after some risk-benefit and risk refinement has been completed.
They said they will announced within 2 days when they plan to next meet, but it will likely be in the next 7 to 10 days.The meeting came the day after both the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) called for a pause on J&J administration after